Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCvc Ig Eur Regulatory News (CVCE)

Share Price Information for Cvc Ig Eur (CVCE)

Share Price is delayed by 15 minutes
Get Live Data
1.055    0.00 (0.00%)
Bid:
1.05
Ask:
1.07
Spread: 0.02 (1.905%)
Market Cap: €292.81m
CVCE Live PriceLast checked at - London Stock Exchange

Intraday Cvc Ig Eur Share Chart

DIVIDEND DECLARATION & DIV TARGET '25(Replacement)

27 Jan 2025 18:15

RNS Number : 8572U
CVC Income & Growth Limited
27 January 2025
 

27 January 2025

 

CVC Income & Growth Limited

 

DIVIDEND DECLARATION & ANNUAL DIVIDEND TARGET '25 (Replacement)

 

The following amendment has been made to the announcement released on 24 January 2025 at 12:53hrs (RNS No. 6613U). In the second paragraph, the quarterly interim dividend per ordinary Euro share has been corrected from 2.486c to 2.0486c. All other details remain unchanged. The full amended text is shown below.

Dividend Declaration and

Annual Dividend Targets for financial year 2025

The information contained within this announcement constitutes inside information.

The Board of Directors of the Company has declared a quarterly interim dividend of 3.3038p per ordinary Sterling Share and 2.0486c per ordinary Euro Share.

These amounts reflect an uplift to the previously indicated quarterly dividend of 2.0625p per Sterling ordinary share and 1.8125c per Euro ordinary share announced by the Company on 30 January 2024.

The ex-dividend date will be 6 February 2025, with the dividends payable on 28 February 2025.

The Board of Directors, in conjunction with the Investment Vehicle Manager, has also completed its periodic review of the Company's annual dividend targets. As a consequence, the Company's annual dividend targets are 9.25p per ordinary Sterling Share (an increase of 1p above 2024) and 7.25c per ordinary Euro Share (unchanged from 2024) with from the first 2025 quarterly interim dividend. This means that the Company's quarterly dividends will be 2.3125p per Sterling Share and 1.8125c per Euro Share, including the Company's first quarter 2025 dividends, payable in the second quarter of 2025.

The Chairman of the Company, Robert Kirkby commented: "The Board of Directors continues to give detailed consideration, not only to the current cash yield of the Investment Vehicle's underlying portfolio by principal reference to its weighted average coupon, but also to market conditions including future trends in default rates and the direction of risk-free rates in the Investment Vehicle's chosen markets, given the Investment Vehicle's predominantly floating rate exposure. The Board is mindful that shareholders expect changes to dividend targets to be made on a sustainable basis, and thus, in the absence of significant and relevant unexpected macroeconomic or geopolitical events, the Company's annual dividend targets should not be changed for at least the next 12 months."

Mr Kirkby added "The Board of Directors also wishes to reconfirm that, in the event that the Investment Vehicle portfolio produces surplus cash income beyond that currently anticipated, an upwards only adjustment will, if appropriate, be made to the Company's fourth quarter 2025 dividends payable in the first quarter of 2026, in a manner similar to that recently announced in respect of the fourth quarter of 2024. There should be no expectation as to the level of any such adjustments or indeed whether such adjustments will arise at all."

The person responsible for arranging for the release of this announcement on behalf of the Company is Sharon A Williams of BNP Paribas S.A., Jersey Branch, Company Secretary.

 

Enquiries:

CVC Income & Growth Limited: +44 (0)1534 815200

Robert Kirkby

BNP Paribas S.A., Jersey Branch: cvcpeolcosec@bnpparibas.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAPFXAFFSEFA
Date   Source Headline
29th Jan 20253:13 pmRNSIssue of Equity
27th Jan 20256:15 pmRNSDIVIDEND DECLARATION & DIV TARGET '25(Replacement)
27th Jan 20257:00 amRNSJANUARY 2025 SHARE CONVERSION
24th Jan 20255:25 pmRNSMONTHLY REPORT
24th Jan 20252:30 pmRNSNet Asset Value Weekly to 17 Jan 2025
24th Jan 202512:53 pmRNSDividend Declaration & Annual Dividend target '25
22nd Jan 20255:08 pmRNSIssue of Equity
22nd Jan 20254:00 pmRNSIssue of Equity
21st Jan 20255:09 pmRNSNet Asset Value Month End 31 Dec 2024
17th Jan 20254:25 pmRNSNet Asset Value Weekly to 10 Jan 2025
17th Jan 20253:58 pmRNSIssue of Equity
16th Jan 20251:05 pmRNSIssue of Equity
15th Jan 20254:24 pmRNSIssue of Equity
14th Jan 20254:37 pmRNSIssue of Equity
10th Jan 20254:47 pmRNSHolding(s) in Company
10th Jan 20254:31 pmRNSIssue of Equity
9th Jan 20255:10 pmRNSNet Asset Value Weekly to 03 Jan 2025
9th Jan 20254:44 pmRNSIssue of Equity
8th Jan 20255:00 pmRNSIssue of Equity
7th Jan 20259:09 amRNSMarch 2025 Semi Annual Tender Restrictions
2nd Jan 20255:10 pmRNSNet Asset Value Weekly to 27 Dec 2024
30th Dec 20241:20 pmRNSNet Asset Value Weekly to 20 Dec 2024
20th Dec 20248:54 amRNSMonthly Report
19th Dec 20245:05 pmRNSNet Asset Value Weekly to 13 Dec 2024
18th Dec 202412:09 pmRNSNet Asset Value Month End 29 Nov 2024
17th Dec 20242:42 pmRNSJANUARY 2025 SHARE CONVERSION
12th Dec 20242:29 pmRNSNet Asset Value Weekly to 06 Dec 2024
5th Dec 202412:10 pmRNSNet Asset Value Weekly to 29 Nov 2024
2nd Dec 20249:49 amRNSTotal Voting Rights
28th Nov 20243:30 pmRNSNet Asset Value Weekly to 22 Nov 2024
22nd Nov 20244:26 pmRNSMonthly Report
22nd Nov 20244:25 pmRNSHolding(s) in Company
22nd Nov 20244:10 pmRNSMonthly Report
20th Nov 20245:10 pmRNSNet Asset Value Weekly to 15 Nov 2024
19th Nov 20249:48 amRNSNet Asset Value Month End 31 Oct 2024
15th Nov 20245:00 pmRNSTotal Voting Rights
14th Nov 20245:45 pmRNSNet Asset Value Weekly to 08 Nov 2024
12th Nov 20242:06 pmRNSDirector/PDMR Shareholding
7th Nov 20242:45 pmRNSNet Asset Value Weekly to 01 Nov 2024
31st Oct 20245:00 pmRNSNet Asset Value Weekly to 25 Oct 2024
31st Oct 20247:00 amRNSSeptember 2024 Tender – Purchase of shares
25th Oct 20247:00 amRNSDividend Declaration
24th Oct 20243:40 pmRNSNet Asset Value Weekly to 18 Oct 2024
21st Oct 20249:36 amRNSSeptember 2024 Tender Price (replacement)
21st Oct 20247:00 amRNSSeptember 2024 Tender Price
18th Oct 20244:34 pmRNSMonthly Report
17th Oct 20245:50 pmRNSNet Asset Value Weekly to 11 Oct 2024
15th Oct 202412:43 pmRNSNet Asset Value Month End 30 Sep 2024
10th Oct 20245:00 pmRNSNet Asset Value Weekly to 04 Oct 2024
4th Oct 20241:50 pmRNSNet Asset Value Weekly to 27 Sep 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.